dalteparin has been researched along with Thrombophilia in 139 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antepartum prophylactic dalteparin does not reduce the occurrence of venous thromboembolism, pregnancy loss, or placenta-mediated pregnancy complications in pregnant women with thrombophilia at high risk of these complications and is associated with an increased risk of minor bleeding." | 9.19 | Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. ( Chan, WS; Clement, AM; Coat, S; Demers, C; Dwyer, J; Greer, IA; Hague, WM; Hinshaw, K; Kahn, SR; Karovitch, A; Keely, E; Khandelwal, M; Khurana, R; Kingdom, J; Kovacs, MJ; Le Gal, G; McDonald, S; McLeod, A; Newstead-Angel, J; Rey, E; Robinson, S; Rodger, MA; Rosene-Montella, K; Said, J; Sermer, M; Silver, RM; Smith, G; Solymoss, S; Walker, M; Wells, PS, 2014) |
| "Our results suggest that the use of long-term prophylactic dalteparin in pregnancy is not associated with a significant decrease in BMD." | 9.12 | Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. ( Clement, AM; Cranney, A; Hague, WM; Hodsman, A; Kahn, SR; Kovacs, MJ; Lazo-Langner, A; Rodger, MA, 2007) |
| " We undertook an international, multicenter, randomized, double-blind, placebo-controlled trial using clinically important outcomes to assess the efficacy and safety of dalteparin in the prevention of venous thromboembolism in such patients." | 9.11 | Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. ( Cohen, AT; Goldhaber, SZ; Leizorovicz, A; Olsson, CG; Turpie, AG; Vaitkus, PT, 2004) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 8.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia." | 7.74 | Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007) |
| "The antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold (LK-732, LK-639 and LK-731) and their amidoxime prodrugs (LK-658, LK-633 and LK-730) was studied in comparison to argatroban and nadroparin in two rat models of venous thrombosis, induced either by complete stasis combined with hypercoagulability (model 1) or by partial stasis combined with vessel injury (model 2)." | 7.73 | Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models. ( Bozic, M; Budihna, MV; Cerne, M; Drevensek, G; Peternel, L; Stalc, A; Stegnar, M; Urleb, U; Zega, A, 2005) |
| "Hypercoagulability is observed in patients with inherited thrombophilia, e." | 6.70 | The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation. ( Eberl, E; Geisen, U; Grossmann, R; Keller, F; Schambeck, CM, 2001) |
| "Dalteparin was not stopped in any women." | 5.91 | Prophylactic Dose of Dalteparin in Pregnant Women With History of Venous Thromboembolisms and/or Thrombophilia: Real-World Data. ( Kozak, M; Novak, A; Novak, P; Šabović, M, 2023) |
| "Stasis ulcers are commonly the result of chronic venous insufficiency." | 5.31 | Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001) |
| "Screening results for thrombophilia and antithrombotic treatment with enoxaparin, aspirin, or both and pregnancy outcomes." | 5.27 | The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages. ( Elias, A; Elias, M; Nahas, R; Saliba, W, 2018) |
| "Antepartum prophylactic dalteparin does not reduce the occurrence of venous thromboembolism, pregnancy loss, or placenta-mediated pregnancy complications in pregnant women with thrombophilia at high risk of these complications and is associated with an increased risk of minor bleeding." | 5.19 | Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. ( Chan, WS; Clement, AM; Coat, S; Demers, C; Dwyer, J; Greer, IA; Hague, WM; Hinshaw, K; Kahn, SR; Karovitch, A; Keely, E; Khandelwal, M; Khurana, R; Kingdom, J; Kovacs, MJ; Le Gal, G; McDonald, S; McLeod, A; Newstead-Angel, J; Rey, E; Robinson, S; Rodger, MA; Rosene-Montella, K; Said, J; Sermer, M; Silver, RM; Smith, G; Solymoss, S; Walker, M; Wells, PS, 2014) |
| "Our results suggest that the use of long-term prophylactic dalteparin in pregnancy is not associated with a significant decrease in BMD." | 5.12 | Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. ( Clement, AM; Cranney, A; Hague, WM; Hodsman, A; Kahn, SR; Kovacs, MJ; Lazo-Langner, A; Rodger, MA, 2007) |
| " We undertook an international, multicenter, randomized, double-blind, placebo-controlled trial using clinically important outcomes to assess the efficacy and safety of dalteparin in the prevention of venous thromboembolism in such patients." | 5.11 | Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. ( Cohen, AT; Goldhaber, SZ; Leizorovicz, A; Olsson, CG; Turpie, AG; Vaitkus, PT, 2004) |
| "Thirty-three patients with atrial fibrillation were randomly treated either with OAT (warfarin 10, 7." | 5.10 | Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation? ( Husted, SE; Lassen, JF; Zeuthen, EL, 2003) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 4.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "A 71-year old gentleman with history of arterial hypertension treated with valsartan presented on was hospitalized at the Infectious Diseases Unit, University of Bologna (Italy) for severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2) and received treatment with hydroxychloroquine 200mg bid (400 mg bid the first day), azithromycin 400 mg qd, thrombotic prophylaxis with enoxaparin 4000 UI qd and Venturi mask oxygen delivering FiO2 of 31%." | 3.96 | Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin. ( Bartoletti, M; Viale, P, 2020) |
| "To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia." | 3.74 | Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007) |
| "The antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold (LK-732, LK-639 and LK-731) and their amidoxime prodrugs (LK-658, LK-633 and LK-730) was studied in comparison to argatroban and nadroparin in two rat models of venous thrombosis, induced either by complete stasis combined with hypercoagulability (model 1) or by partial stasis combined with vessel injury (model 2)." | 3.73 | Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models. ( Bozic, M; Budihna, MV; Cerne, M; Drevensek, G; Peternel, L; Stalc, A; Stegnar, M; Urleb, U; Zega, A, 2005) |
| "Heparin prophylaxis at fixed low doses and possibly aspirin could be efficacious in preventing adverse outcomes in women carrying inherited thrombophilia with previous poor obstetric outcomes." | 3.71 | Preventing adverse obstetric outcomes in women with genetic thrombophilia. ( Brancaccio, V; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Pavone, G; Sciannamé, N, 2002) |
| " The relationship between warfarin induced skin necrosis and level of anticoagulation was investigated." | 3.70 | Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin. ( Andrew, M; Halton, J; Jardine, L; Johnston, M; Marlar, R; Massicotte, MP; Monagle, P; Vegh, P; Webber, C, 1998) |
| " Aspirin, 75 mg daily was given in addition to enoxaparin to women with antiphospholipid syndrome." | 3.70 | Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. ( Blumenfeld, Z; Brenner, B; Hoffman, R; Weiner, Z; Younis, JS, 2000) |
| "Aspirin and heparin have been shown to have potentially beneficial effects on trophoblast implantation." | 2.79 | Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. ( Adam, I; Ashur, BM; Elbareg, AM; Elmahashi, MO; Essadi, FM, 2014) |
| "In more than half of all recurrent miscarriage the cause still remains uncertain." | 2.76 | Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. ( Bloemenkamp, KW; Helmerhorst, FM; Kaaja, RJ; Lampinen, K; Morin-Papunen, L; Ulander, VM; Visser, J, 2011) |
| " There is a lack of consensus in guidelines regarding the timing of administration and the dosage of thromboprophylactic agents." | 2.75 | Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography. ( Attaran, S; Awad, WI; Somov, P, 2010) |
| "In women with a history of recurrent miscarriage, the risk of miscarriage in a subsequent pregnancy is about 30% to 40%." | 2.74 | Use of heparin in women with early and late miscarriages with and without thrombophilia. ( Baumgarten, S; Dörner, T; Kadecki, O; Kiesewetter, H; Monien, S; Salama, A, 2009) |
| "Forty-one consecutive children with acute lymphoblastic leukemia (ALL) received prophylaxis therapy with the low molecular weight heparin (LMWH) enoxaparin during L-asparaginase treatment." | 2.70 | Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. ( Ben Barak, A; Brenner, B; Elhasid, R; Lanir, N; Levin, C; Postovsky, S; Sharon, R; Weyl Ben Arush, M, 2001) |
| "Hypercoagulability is observed in patients with inherited thrombophilia, e." | 2.70 | The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation. ( Eberl, E; Geisen, U; Grossmann, R; Keller, F; Schambeck, CM, 2001) |
| "11 patients with breast cancer and 10 patients with lung cancer receiving systemic chemotherapy were studied." | 2.70 | Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation. ( Israel, VK; Liebman, HA; Presant, CA; Rochanda, L; Waisman, JR; Weitz, IC, 2002) |
| "The composite endpoint of screened deep vein thrombosis (DVT) and symptomatic pulmonary embolism (PE) during prophylaxis did not differ significantly between patients with or without these mutations." | 2.70 | Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. ( Andersson, C; Bylock, A; Eriksson, BI; Frison, L; Gustafsson, D; Larson, G; Lindahl, TL; Wåhlander, K, 2002) |
| " We used American College of Obstetrics and Gynecology recommendations as the base for screening and dosing guidelines and utilized known and published absolute risk values and odds ratios to stratify risk factors." | 2.61 | Risk Assessment and Treatment Guide for Obstetric Thromboprophylaxis: Comprehensive Review of Current Guidelines. ( Deering, SH; Eubanks, AA; Thiel, LM, 2019) |
| "Cardiovascular disease, to which venous thrombosis and pulmonary embolism contribute a major part, are the leading cause of death in industrialized countries." | 2.42 | [Venous thrombosis and thrombophilic management of prevention and therapy]. ( Katus, HA; Ruef, J, 2003) |
| "Women with thrombophilia have an increased risk of pregnancy loss and possibly other serious obstetric complications, although definition of the magnitude of risk will require prospective longitudinal studies." | 2.42 | Thrombophilia and pregnancy complications. ( Kujovich, JL, 2004) |
| "The third pregnancy was established and sintrom was stopped and replaced by fraxiparine 0." | 2.40 | [Successful prophylaxis in a pregnancy with thrombophilic states]. ( Bogdanova, M; Iankova, Z, 1999) |
| "Dalteparin was not stopped in any women." | 1.91 | Prophylactic Dose of Dalteparin in Pregnant Women With History of Venous Thromboembolisms and/or Thrombophilia: Real-World Data. ( Kozak, M; Novak, A; Novak, P; Šabović, M, 2023) |
| "Hyperhomocysteinemia is a metabolic disorder caused by various enzyme defects in methionine metabolism." | 1.51 | Multifactorial Painful Leg Ulcers Due to Hyperhomocysteinemia, Plasminogen Activator Inhibitor-1 4G/5G Heterozygote Gene Mutation, and Beta Thalassemia Minor: A Case Report. ( Büyükbabani, N; Çaytemel, C; Topaloğlu Demir, F; Türkoğlu, Z; Uzuner, EG, 2019) |
| "Presumptive diagnosis of pulmonary embolism was made and the patient was given 1000IU of antithrombin III and nadroparine (2x90IU/kg/24h s." | 1.48 | [Pulmonary embolism in a girl with nephrotic syndrome and factor V Leiden - case report]. ( Biejat, A; Brzewski, M; Kucińska, B; Kułagowska, J; Mizerska-Wasiak, M; Ofiara, A; Pańczyk-Tomaszewska, M; Skrzypczyk, P; Szyszka, M; Werner, B, 2018) |
| "We aimed to determine the outcome of threatened abortion in women treated with low-molecular weight heparin (LMWH) for recurrent pregnancy loss (RPL)." | 1.46 | Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss. ( Amsalem, H; Kalish, Y; Kleinstern, G; Rottenstreich, A, 2017) |
| "Workup revealed bilateral submassive pulmonary embolism and proximal right lower extremity deep vein thrombosis." | 1.43 | Inherited antithrombin deficiency and anabolic steroids: a risky combination. ( Choe, H; DeSancho, MT; Elfil, M, 2016) |
| "Among patients with cancer-related VTE, 59." | 1.38 | Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study. ( Blostein, M; Faucher, JP; Gamble, G; Game, M; Gordon, W; Kagoma, PK; Kahn, SR; Komari, N; Laverdière, D; Martineau, J; McLeod, A; Mills, A; Miron, MJ; Schulman, S; Springmann, V; Stewart, JA; Strulovitch, C, 2012) |
| "The incidence of severe pregnancy complications in previous pregnancies was similar in both groups." | 1.37 | Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications. ( Gamzu, R; Kupferminc, MJ; Lessing, JB; Many, A; Rimon, E; Sharon, M, 2011) |
| "Eighty percent of deep venous thrombosis resolves spontaneously and less than 15% embolize to pulmonary arteries." | 1.37 | Saddle pulmonary thromboembolism with zero Wells' score. ( Brown, TA; Kangath, RV; Pai, RP, 2011) |
| "Gastrointestinal stromal tumors are the commonest stromal tumors of the digestive tract." | 1.36 | [Gastrointestinal stromal tumor in pregnancy and control. Case report]. ( Cuerva-González, MJ; de la Calle-Fernández, M; Lacoponi, S; Pozo-Krielinger, J, 2010) |
| "Eighteen patients were found to have a genetic predisposition for TE, all of them received prophylactic LMWH." | 1.36 | Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. ( Ben Arush, MW; Brenner, B; Elhasid, R; Harlev, D; Sarig, G; Zaidman, I, 2010) |
| "Only cases with renal failure, morbid obesity or extreme age require anti-Xa monitoring to assure the therapeutic level achievement." | 1.36 | Stability of plasma anti-Xa activity in low-molecular-weight heparin monitoring. ( Akkawat, B; Juntiang, J; Rojnuckarin, P, 2010) |
| "Authors describe a case of systemic sclerosis with deep venous thrombosis." | 1.34 | [Hereditary thrombophilia and systemic sclerosis. An unusual case report]. ( Albanese, L; D'Amore, M; D'Amore, S; Minenna, G; Scagliusi, P, 2007) |
| "Inherited thrombophilia is associated with thromboembolic events and/or poor obstetric outcome." | 1.33 | Inherited thrombophilia: treatment during pregnancy. ( Caruso, A; De Carolis, S; De Stefano, V; Fatigante, G; Ferrazzani, S; Garofalo, S; Leone, G; Rossi, E, 2006) |
| "High cholesterol levels are a known risk factor for coronary events." | 1.31 | Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin. ( Baetta, R; Camera, M; Comparato, C; Ezekowitz, MD; Fuortes, M; Paoletti, R; Rossi, F; Toschi, V; Tremoli, E, 2002) |
| "Stasis ulcers are commonly the result of chronic venous insufficiency." | 1.31 | Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.88) | 18.2507 |
| 2000's | 70 (50.36) | 29.6817 |
| 2010's | 55 (39.57) | 24.3611 |
| 2020's | 10 (7.19) | 2.80 |
| Authors | Studies |
|---|---|
| Brüggemann, R | 1 |
| Gietema, H | 1 |
| Jallah, B | 1 |
| Ten Cate, H | 2 |
| Stehouwer, C | 1 |
| Spaetgens, B | 1 |
| Simeone, R | 1 |
| Giacomello, R | 1 |
| Bruno, G | 1 |
| Parco, S | 1 |
| Maximova, N | 1 |
| Martinelli, M | 1 |
| Zito, G | 1 |
| Luppi, S | 1 |
| Cervi, G | 1 |
| Ricci, G | 1 |
| Skrzypczyk, P | 1 |
| Mizerska-Wasiak, M | 1 |
| Ofiara, A | 1 |
| Szyszka, M | 1 |
| Kułagowska, J | 1 |
| Biejat, A | 1 |
| Brzewski, M | 1 |
| Kucińska, B | 1 |
| Werner, B | 1 |
| Pańczyk-Tomaszewska, M | 1 |
| de Jong, PG | 2 |
| Kaandorp, S | 1 |
| Di Nisio, M | 1 |
| Goddijn, M | 2 |
| Middeldorp, S | 2 |
| Spronk, HM | 1 |
| De Jong, AM | 1 |
| Verheule, S | 1 |
| De Boer, HC | 1 |
| Maass, AH | 1 |
| Lau, DH | 1 |
| Rienstra, M | 1 |
| van Hunnik, A | 1 |
| Kuiper, M | 1 |
| Lumeij, S | 1 |
| Zeemering, S | 1 |
| Linz, D | 1 |
| Kamphuisen, PW | 1 |
| Crijns, HJ | 1 |
| Van Gelder, IC | 1 |
| van Zonneveld, AJ | 1 |
| Schotten, U | 1 |
| Camporese, G | 1 |
| Bernardi, E | 1 |
| Noventa, F | 1 |
| Lewandowski, K | 1 |
| Balcerzak, A | 1 |
| Kubiaczyk-Paluch, B | 1 |
| Breborowicz, GH | 1 |
| Peternel, L | 1 |
| Stegnar, M | 1 |
| Drevensek, G | 1 |
| Budihna, MV | 1 |
| Bozic, M | 1 |
| Zega, A | 1 |
| Stalc, A | 1 |
| Cerne, M | 1 |
| Urleb, U | 1 |
| Boda, Z | 1 |
| László, P | 1 |
| Pfliegler, G | 1 |
| Tornai, I | 1 |
| Rejtö, L | 1 |
| Schlammadinger, A | 1 |
| Iankova, Z | 1 |
| Bogdanova, M | 1 |
| Kargin, VD | 1 |
| Rzhevskaia, VN | 1 |
| Saltykova, NB | 1 |
| Kapustin, SI | 1 |
| Papaian, LP | 1 |
| Lozano, R | 1 |
| Franco, ME | 1 |
| Muñoa, L | 1 |
| González, AB | 1 |
| Díaz de Rada, P | 1 |
| Valentí, A | 1 |
| Valentí, JR | 1 |
| Çaytemel, C | 1 |
| Topaloğlu Demir, F | 1 |
| Büyükbabani, N | 1 |
| Türkoğlu, Z | 1 |
| Uzuner, EG | 1 |
| Glueck, CJ | 5 |
| Freiberg, RA | 4 |
| Wang, P | 5 |
| Viale, P | 1 |
| Bartoletti, M | 1 |
| Del Castillo, R | 1 |
| Martinez, D | 1 |
| Sarria, GJ | 1 |
| Pinillos, L | 1 |
| Garcia, B | 1 |
| Castillo, L | 1 |
| Carhuactocto, A | 1 |
| Giordano, FA | 1 |
| Sarria, GR | 1 |
| Lemos, ACB | 1 |
| do Espírito Santo, DA | 1 |
| Salvetti, MC | 1 |
| Gilio, RN | 1 |
| Agra, LB | 1 |
| Pazin-Filho, A | 1 |
| Miranda, CH | 1 |
| Arachchillage, DRJ | 1 |
| Shi, C | 1 |
| Saliu, D | 1 |
| Kozman, P | 1 |
| Mi, E | 1 |
| Buti, N | 1 |
| Kashef, E | 1 |
| Copley, SJ | 1 |
| Gomez, C | 1 |
| Leonard, R | 1 |
| Aziz, R | 1 |
| Shlebak, AA | 1 |
| Laffan, M | 1 |
| Stillson, JE | 1 |
| Bunch, CM | 1 |
| Gillespie, L | 1 |
| Khan, R | 1 |
| Wierman, M | 1 |
| Pulvirenti, J | 1 |
| Phyu, H | 1 |
| Anderson, S | 1 |
| Al-Fadhl, M | 1 |
| Thomas, AV | 1 |
| Kwaan, HC | 1 |
| Moore, E | 1 |
| Moore, H | 1 |
| Walsh, MM | 1 |
| Farooqui, AB | 1 |
| Humbert, ML | 1 |
| Montague, MS | 1 |
| Doré, S | 1 |
| Simpkins, AN | 1 |
| Rottenstreich, A | 1 |
| Amsalem, H | 1 |
| Kleinstern, G | 1 |
| Kalish, Y | 1 |
| Eubanks, AA | 1 |
| Deering, SH | 1 |
| Thiel, LM | 1 |
| Martín Guerra, JM | 1 |
| Asenjo, MM | 1 |
| Dueñas Gutiérrez, CJ | 1 |
| Gil González, I | 1 |
| Garmi, G | 2 |
| Zafran, N | 1 |
| Okopnik, M | 1 |
| Gavish, I | 2 |
| Romano, S | 2 |
| Salim, R | 2 |
| Schaal, JV | 1 |
| Benhamou, D | 1 |
| Boyer, K | 1 |
| Mercier, FJ | 1 |
| Papageorgiou, C | 1 |
| Vandreden, P | 1 |
| Marret, E | 1 |
| Bonnet, F | 1 |
| Robert, F | 1 |
| Spyropoulos, A | 1 |
| Galea, V | 1 |
| Elalamy, I | 1 |
| Hatmi, M | 1 |
| Gerotziafas, GT | 1 |
| Elmahashi, MO | 1 |
| Elbareg, AM | 1 |
| Essadi, FM | 1 |
| Ashur, BM | 1 |
| Adam, I | 1 |
| Cohen, HV | 1 |
| Gurung, S | 1 |
| Quek, SY | 1 |
| Subramanian, G | 1 |
| Abbas, A | 1 |
| Patel, N | 1 |
| Singhal, D | 1 |
| Newman, B | 1 |
| Rajpurkar, M | 1 |
| Ozgonenel, B | 1 |
| Lal, A | 1 |
| Kuriakose, P | 1 |
| Azık, F | 1 |
| Gökçebay, DG | 1 |
| Tavil, B | 1 |
| Işık, P | 1 |
| Tunç, B | 1 |
| Uçkan, D | 1 |
| Russell, CE | 1 |
| Wadhera, RK | 1 |
| Piazza, G | 1 |
| Quenby, S | 1 |
| Bloemenkamp, KW | 2 |
| Braams-Lisman, BA | 1 |
| de Bruin, JP | 1 |
| Coomarasamy, A | 1 |
| David, M | 2 |
| DeSancho, MT | 2 |
| van der Heijden, OW | 1 |
| Hoek, A | 1 |
| Hutten, BA | 1 |
| Jochmans, K | 1 |
| Koks, CA | 1 |
| Kuchenbecker, WK | 1 |
| Mol, BW | 1 |
| Torrance, HL | 1 |
| Scheepers, HC | 1 |
| Stephenson, MD | 1 |
| Verhoeve, HR | 1 |
| Visser, J | 2 |
| de Vries, JI | 1 |
| Kooistra, HA | 1 |
| Gebel, M | 1 |
| Sahin, K | 1 |
| Lensing, AW | 1 |
| Meijer, K | 1 |
| Choe, H | 1 |
| Elfil, M | 1 |
| Mastrolia, SA | 1 |
| Novack, L | 1 |
| Thachil, J | 2 |
| Rabinovich, A | 1 |
| Pikovsky, O | 1 |
| Klaitman, V | 1 |
| Loverro, G | 1 |
| Erez, O | 1 |
| Nachum, Z | 1 |
| Braverman, M | 1 |
| Nahas, R | 1 |
| Saliba, W | 1 |
| Elias, A | 1 |
| Elias, M | 1 |
| Narin, C | 1 |
| Reyhanoglu, H | 1 |
| Tülek, B | 1 |
| Onoglu, R | 1 |
| Ege, E | 1 |
| Sarigül, A | 1 |
| Yeniterzi, M | 1 |
| Durmaz, I | 1 |
| Alhadad, A | 1 |
| Acosta, S | 1 |
| Sarabi, L | 1 |
| Kölbel, T | 1 |
| Qublan, H | 1 |
| Amarin, Z | 1 |
| Dabbas, M | 1 |
| Farraj, AE | 1 |
| Beni-Merei, Z | 1 |
| Al-Akash, H | 1 |
| Bdoor, AN | 1 |
| Nawasreh, M | 1 |
| Malkawi, S | 1 |
| Diab, F | 1 |
| Al-Ahmad, N | 1 |
| Balawneh, M | 1 |
| Abu-Salim, A | 1 |
| Albaladejo, P | 1 |
| Ozçakar, L | 1 |
| Dönmez, G | 1 |
| Yörübulut, M | 1 |
| Aydog, ST | 1 |
| Demirel, H | 1 |
| Pasaoglu, I | 1 |
| Doral, MN | 1 |
| O'Brien, SH | 1 |
| Smith, KJ | 2 |
| Peral, D | 1 |
| Higueras, R | 1 |
| Onrubia, X | 1 |
| Bellver, J | 1 |
| Rojnuckarin, P | 1 |
| Akkawat, B | 1 |
| Juntiang, J | 1 |
| Salomon, O | 1 |
| Dulitzky, M | 1 |
| Apter, S | 1 |
| Friedrich, E | 1 |
| Hameed, AB | 1 |
| Bustelos, R | 1 |
| Ayala, R | 1 |
| Martinez, J | 1 |
| Martin, MA | 1 |
| Toledo, T | 1 |
| Grande, S | 1 |
| Garfia, C | 1 |
| Moreno, A | 1 |
| Perez, B | 1 |
| Meneu, JC | 1 |
| Moreno, E | 1 |
| Ribera, C | 1 |
| Byrne, M | 2 |
| Reynolds, JV | 1 |
| O'Donnell, JS | 1 |
| Keogan, M | 1 |
| White, B | 1 |
| Murphy, S | 1 |
| Maher, SG | 1 |
| Pidgeon, GP | 1 |
| Attaran, S | 1 |
| Somov, P | 1 |
| Awad, WI | 1 |
| Harlev, D | 1 |
| Zaidman, I | 1 |
| Sarig, G | 3 |
| Ben Arush, MW | 1 |
| Brenner, B | 8 |
| Elhasid, R | 2 |
| Diaz, JA | 1 |
| Hawley, AE | 1 |
| Alvarado, CM | 1 |
| Berguer, AM | 1 |
| Baker, NK | 1 |
| Wrobleski, SK | 1 |
| Wakefield, TW | 1 |
| Lucchesi, BR | 1 |
| Myers, DD | 1 |
| Sudrová, M | 1 |
| Kvasnička, J | 1 |
| Kudrnová, Z | 1 |
| Zenáhlíková, Z | 1 |
| Mazoch, J | 1 |
| Brzežková, R | 1 |
| Gheorghiade, M | 1 |
| Thyssen, A | 1 |
| Zolynas, R | 1 |
| Nadar, VK | 1 |
| Greenberg, BH | 1 |
| Mehra, M | 1 |
| Sun, X | 1 |
| Tian, H | 1 |
| Plotnikov, AN | 1 |
| Burton, P | 1 |
| Ulander, VM | 1 |
| Helmerhorst, FM | 1 |
| Lampinen, K | 1 |
| Morin-Papunen, L | 1 |
| Kaaja, RJ | 1 |
| Sucak, A | 1 |
| Acar, K | 1 |
| Celen, S | 1 |
| Danisman, N | 1 |
| Sucak, GT | 1 |
| Kupferminc, MJ | 1 |
| Rimon, E | 1 |
| Many, A | 1 |
| Sharon, M | 1 |
| Lessing, JB | 1 |
| Gamzu, R | 1 |
| Pai, RP | 1 |
| Kangath, RV | 1 |
| Brown, TA | 1 |
| Cuerva-González, MJ | 1 |
| Lacoponi, S | 1 |
| de la Calle-Fernández, M | 1 |
| Pozo-Krielinger, J | 1 |
| Shrestha, P | 1 |
| Basnyat, B | 1 |
| Küpper, T | 1 |
| van der Giet, S | 1 |
| Kahn, SR | 5 |
| Springmann, V | 1 |
| Schulman, S | 1 |
| Martineau, J | 1 |
| Stewart, JA | 1 |
| Komari, N | 1 |
| McLeod, A | 2 |
| Strulovitch, C | 1 |
| Blostein, M | 2 |
| Faucher, JP | 1 |
| Gamble, G | 1 |
| Gordon, W | 1 |
| Kagoma, PK | 1 |
| Miron, MJ | 1 |
| Laverdière, D | 1 |
| Game, M | 1 |
| Mills, A | 1 |
| Figueiró-Filho, EA | 1 |
| de Oliveira, VM | 1 |
| Breda, I | 1 |
| Coelho, LR | 1 |
| Ferreira, CM | 1 |
| Grandone, E | 2 |
| Brancaccio, V | 1 |
| Colaizzo, D | 2 |
| Sciannamé, N | 1 |
| Pavone, G | 1 |
| Di Minno, G | 1 |
| Margaglione, M | 2 |
| Bergqvist, D | 1 |
| Bergmann, JF | 1 |
| Mouly, S | 1 |
| Carp, H | 2 |
| Dolitzky, M | 1 |
| Inbal, A | 1 |
| Ruef, J | 1 |
| Katus, HA | 1 |
| Gris, JC | 2 |
| Mercier, E | 1 |
| Quéré, I | 1 |
| Lavigne-Lissalde, G | 1 |
| Cochery-Nouvellon, E | 1 |
| Hoffet, M | 1 |
| Ripart-Neveu, S | 1 |
| Tailland, ML | 1 |
| Dauzat, M | 1 |
| Marès, P | 2 |
| Covin, RB | 1 |
| Rich, NL | 1 |
| Aysola, A | 1 |
| Kujovich, JL | 1 |
| Goldenberg, N | 1 |
| Sieve, L | 2 |
| Hoffman, R | 2 |
| Dulitsky, M | 1 |
| Younis, J | 1 |
| Becker, RC | 1 |
| Bar, J | 1 |
| Ellis, M | 1 |
| Yarom, I | 1 |
| Yohai, D | 1 |
| Samueloff, A | 1 |
| Blumenfeld, Z | 2 |
| Leiba, R | 1 |
| Lanir, N | 2 |
| De Carolis, S | 1 |
| Ferrazzani, S | 1 |
| De Stefano, V | 2 |
| Garofalo, S | 1 |
| Fatigante, G | 1 |
| Rossi, E | 2 |
| Leone, G | 1 |
| Caruso, A | 1 |
| Lindqvist, PG | 3 |
| Merlo, J | 1 |
| Aggarwal, A | 1 |
| Nadir, Y | 1 |
| Mazor, Y | 1 |
| Reuven, B | 1 |
| Krivoy, N | 1 |
| Puértolas Ortega, M | 1 |
| Izquierdo Villarroya, B | 1 |
| Oliva Perales, P | 1 |
| Lafuente Ojeda, N | 1 |
| Izquierdo Villarroya, J | 1 |
| Ruiz Pérez, R | 1 |
| Cardoso, R | 1 |
| Gonçalo, M | 1 |
| Tellechea, O | 1 |
| Maia, R | 1 |
| Borges, C | 1 |
| Silva, JA | 1 |
| Figueiredo, A | 1 |
| Alli, NA | 1 |
| Wainwright, RD | 1 |
| Mackinnon, D | 1 |
| Poyiadjis, S | 1 |
| Naidu, G | 1 |
| Minenna, G | 1 |
| Albanese, L | 1 |
| D'Amore, S | 1 |
| Scagliusi, P | 1 |
| D'Amore, M | 1 |
| Bick, RL | 3 |
| Elidemir, O | 1 |
| Schecter, MG | 1 |
| Seethamraju, H | 1 |
| Mahoney, DH | 1 |
| McKenzie, ED | 1 |
| Mallory, GB | 1 |
| Cappucci, F | 1 |
| Fernández-Meré, LA | 1 |
| Fernández Rogríguez, S | 1 |
| Alvarez-Blanco, M | 1 |
| Mannari, D | 1 |
| Liu, C | 1 |
| Hughes, D | 1 |
| Mehta, A | 1 |
| Monagle, P | 1 |
| Andrew, M | 1 |
| Halton, J | 1 |
| Marlar, R | 1 |
| Jardine, L | 1 |
| Vegh, P | 1 |
| Johnston, M | 1 |
| Webber, C | 1 |
| Massicotte, MP | 1 |
| Finkelstein, Y | 1 |
| Aloni, D | 1 |
| Kimia, A | 1 |
| Sommer, R | 1 |
| Sirota, L | 1 |
| Ellis, MH | 1 |
| Manor, Y | 1 |
| Witz, M | 1 |
| Weiner, Z | 1 |
| Younis, JS | 1 |
| Dahlbäck, B | 1 |
| Fontaine, RN | 1 |
| Tracy, T | 1 |
| Sharon, R | 1 |
| Weyl Ben Arush, M | 1 |
| Levin, C | 1 |
| Postovsky, S | 1 |
| Ben Barak, A | 1 |
| Bendz, B | 1 |
| Sevre, K | 1 |
| Andersen, TO | 1 |
| Sandset, PM | 1 |
| Sarto, A | 1 |
| Rocha, M | 1 |
| Geller, M | 1 |
| Capmany, C | 1 |
| Martínez, M | 1 |
| Quintans, C | 1 |
| Donaldson, M | 1 |
| Pasqualini, RS | 1 |
| Ellison, J | 1 |
| Thomson, AJ | 1 |
| Conkie, JA | 1 |
| McCall, F | 1 |
| Walker, D | 1 |
| Greer, A | 1 |
| Camera, M | 1 |
| Toschi, V | 1 |
| Comparato, C | 1 |
| Baetta, R | 1 |
| Rossi, F | 1 |
| Fuortes, M | 1 |
| Ezekowitz, MD | 1 |
| Paoletti, R | 1 |
| Tremoli, E | 1 |
| Vrij, AA | 1 |
| Oberndorff-Klein-Woolthuis, A | 1 |
| Dijkstra, G | 1 |
| de Jong, AE | 1 |
| Wagenvoord, R | 1 |
| Hemker, HC | 1 |
| Stockbrügger, RW | 1 |
| Breddin, HK | 1 |
| Novak, P | 1 |
| Novak, A | 1 |
| Šabović, M | 1 |
| Kozak, M | 1 |
| Hecking, C | 1 |
| Hendelmeier, M | 1 |
| von Bardeleben, R | 1 |
| Gröschel, K | 1 |
| Schinzel, H | 2 |
| Gibson, PS | 1 |
| Nerenberg, KA | 1 |
| Rodger, MA | 3 |
| Hague, WM | 3 |
| Kingdom, J | 3 |
| Karovitch, A | 1 |
| Sermer, M | 2 |
| Clement, AM | 3 |
| Coat, S | 1 |
| Chan, WS | 1 |
| Said, J | 1 |
| Rey, E | 3 |
| Robinson, S | 1 |
| Khurana, R | 2 |
| Demers, C | 1 |
| Kovacs, MJ | 3 |
| Solymoss, S | 2 |
| Hinshaw, K | 1 |
| Dwyer, J | 1 |
| Smith, G | 1 |
| McDonald, S | 1 |
| Newstead-Angel, J | 1 |
| Khandelwal, M | 1 |
| Silver, RM | 1 |
| Le Gal, G | 1 |
| Greer, IA | 1 |
| Keely, E | 1 |
| Rosene-Montella, K | 1 |
| Walker, M | 1 |
| Wells, PS | 2 |
| Madahar, P | 1 |
| Gonzalez, CM | 1 |
| Ferrazzi, EM | 1 |
| Gervasi, MT | 1 |
| Simioni, P | 1 |
| Hunt, BJ | 1 |
| Seed, PT | 1 |
| Lefkou, E | 1 |
| Gerdsen, F | 1 |
| Luxembourg, B | 1 |
| Langer, F | 1 |
| Bauersachs, R | 1 |
| Lindhoff-Last, E | 1 |
| Dindo, D | 1 |
| Breitenstein, S | 1 |
| Hahnloser, D | 1 |
| Seifert, B | 1 |
| Yakarisik, S | 1 |
| Asmis, LM | 1 |
| Muller, MK | 1 |
| Clavien, PA | 1 |
| Monien, S | 1 |
| Kadecki, O | 1 |
| Baumgarten, S | 1 |
| Salama, A | 1 |
| Dörner, T | 1 |
| Kiesewetter, H | 1 |
| Eldor, A | 1 |
| Weitz, IC | 1 |
| Israel, VK | 1 |
| Waisman, JR | 1 |
| Presant, CA | 1 |
| Rochanda, L | 1 |
| Liebman, HA | 1 |
| Alfar, H | 1 |
| Goedecke, C | 1 |
| Zeuthen, EL | 1 |
| Lassen, JF | 1 |
| Husted, SE | 1 |
| Arnesen, H | 1 |
| Dahl, OE | 1 |
| Aspelin, T | 1 |
| Seljeflot, I | 1 |
| Kierulf, P | 1 |
| Lyberg, T | 1 |
| Leizorovicz, A | 1 |
| Cohen, AT | 1 |
| Turpie, AG | 1 |
| Olsson, CG | 1 |
| Vaitkus, PT | 1 |
| Goldhaber, SZ | 1 |
| Abou-Nassar, K | 1 |
| Wells, P | 1 |
| Doucette, S | 1 |
| Ramsay, T | 1 |
| Mackinnon, K | 1 |
| Rodger, M | 1 |
| Cranney, A | 1 |
| Hodsman, A | 1 |
| Lazo-Langner, A | 1 |
| Leduc, L | 1 |
| Dubois, E | 1 |
| Takser, L | 1 |
| Krafft, A | 1 |
| Bauersachs, RM | 1 |
| Dudenhausen, J | 1 |
| Faridi, A | 1 |
| Fischer, T | 1 |
| Fung, S | 1 |
| Geisen, U | 2 |
| Harenberg, J | 1 |
| Herchenhan, E | 1 |
| Keller, F | 2 |
| Kemkes-Matthes, B | 1 |
| Spannagl, M | 1 |
| Thaler, CJ | 1 |
| Scott, RG | 1 |
| Schambeck, CM | 1 |
| Eberl, E | 1 |
| Grossmann, R | 1 |
| Tomita, N | 1 |
| Kanamori, H | 1 |
| Fujita, H | 1 |
| Maruta, A | 1 |
| Naitoh, A | 1 |
| Nakamura, S | 1 |
| Ota, Y | 1 |
| Nozue, N | 1 |
| Kihara, M | 1 |
| Ishigatsubo, Y | 1 |
| Antovic, A | 1 |
| Blombäck, M | 1 |
| Bremme, K | 1 |
| He, S | 1 |
| Wåhlander, K | 1 |
| Larson, G | 1 |
| Lindahl, TL | 1 |
| Andersson, C | 1 |
| Frison, L | 1 |
| Gustafsson, D | 1 |
| Bylock, A | 1 |
| Eriksson, BI | 1 |
| Takci, Z | 1 |
| Ozoguz, P | 1 |
| Dendrinos, S | 1 |
| Kalogirou, I | 1 |
| Makrakis, E | 1 |
| Theodoridis, T | 1 |
| Mahmound, EA | 1 |
| Christopoulou-Cokkinou, V | 1 |
| Creatsas, G | 1 |
| Chen, YW | 1 |
| Khorana, AA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss ,Double Blinded Randomized Controlled Trial .[NCT05237843] | Phase 1 | 70 participants (Anticipated) | Interventional | 2022-03-01 | Not yet recruiting | ||
| Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage[NCT01917799] | Phase 4 | 150 participants (Anticipated) | Interventional | 2009-01-31 | Recruiting | ||
| Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome[NCT01068795] | 144 participants (Actual) | Interventional | 2009-07-31 | Completed | |||
| [NCT00319176] | 15 participants (Anticipated) | Observational | 2004-04-30 | Completed | |||
| TIPPS - Thrombophilia in Pregnancy Prophylaxis Study: A Multicentre, Multinational, Randomized Control Trial of Prophylaxis Low Molecular Weight Heparin (LMWH) in High-risk Thrombophilic Women.[NCT00967382] | Phase 3 | 292 participants (Actual) | Interventional | 2000-07-31 | Completed | ||
| Analysis of Pro-coagulant and Thrombin-generation Markers for the Prediction of Therapeutic Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism: A Pilot Study[NCT01602445] | 700 participants (Anticipated) | Observational | 2012-07-31 | Completed | |||
| Weight Based Enoxaparin for Venous Thromboembolism Prophylaxis in Trauma Patients[NCT01916707] | Phase 4 | 1,200 participants (Anticipated) | Interventional | 2013-07-31 | Active, not recruiting | ||
| Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study[NCT02066454] | Phase 3 | 105 participants (Anticipated) | Interventional | 2014-04-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for dalteparin and Thrombophilia
| Article | Year |
|---|---|
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Heparin, | 2014 |
[Prevention of deep venous thrombosis after knee arthroscopy. Recent advances].
Topics: Anticoagulants; Arthroscopy; Combined Modality Therapy; Follow-Up Studies; Hemorrhage; Humans; Incid | 2009 |
[Successful prophylaxis in a pregnancy with thrombophilic states].
Topics: Acenocoumarol; Adult; Anticoagulants; Drug Therapy, Combination; Female; Gravidity; Humans; Nadropar | 1999 |
Rivaroxaban is as efficient and safe as bemiparin as thromboprophylaxis in knee arthroscopy.
Topics: Adult; Aged; Arthroscopy; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Follow-Up Studies; Hepa | 2014 |
Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Combined | 2020 |
Risk Assessment and Treatment Guide for Obstetric Thromboprophylaxis: Comprehensive Review of Current Guidelines.
Topics: Anticoagulants; Enoxaparin; Female; Heparin; Humans; Postpartum Period; Practice Guidelines as Topic | 2019 |
Blood clots. Good when you're bleeding; bad when you're not bleeding hypercoagulability and thrombophilia--overview and case report.
Topics: Adult; Anticoagulants; Antithrombin III Deficiency; Blood Coagulation; Dental Care for Chronically I | 2014 |
Mesenteric venous thrombosis.
Topics: Abdominal Pain; Adult; Anticoagulants; Colectomy; Colitis, Ulcerative; Enoxaparin; Fibrinolysis; Hum | 2015 |
LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and meta-analysis.
Topics: Enoxaparin; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; Humans; Pre-Eclampsia; | 2016 |
Venous thromboembolism in cancer patients: expanding horizons.
Topics: Antineoplastic Agents; Double-Blind Method; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular- | 2002 |
Thromboprophylaxis in medical patients: focus on France.
Topics: Acute Disease; Adult; Aged; Attitude of Health Personnel; Cardiovascular Diseases; Double-Blind Meth | 2002 |
[Venous thrombosis and thrombophilic management of prevention and therapy].
Topics: Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Risk Factors; Thrombophilia; | 2003 |
Thrombophilia and pregnancy complications.
Topics: Abortion, Habitual; Enoxaparin; Factor V; Female; Fetal Growth Retardation; Fibrinolytic Agents; Hum | 2004 |
Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature.
Topics: Anemia, Sickle Cell; Anticoagulants; Catheterization; Child; Diagnosis, Differential; Edema; Enoxapa | 2007 |
Antiphospholipid syndrome in pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2008 |
Reviparin sodium - a new low molecular weight heparin.
Topics: Absorption; Anticoagulants; Child; Drug Evaluation; Factor Xa Inhibitors; Female; Heparin, Low-Molec | 2002 |
The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy.
Topics: Abortion, Habitual; Analgesia, Epidural; Anticoagulants; Bone Density; Dalteparin; Female; Guideline | 2002 |
35 trials available for dalteparin and Thrombophilia
| Article | Year |
|---|---|
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID).
Topics: Adult; Aged; Anticoagulants; Brazil; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule | 2020 |
Placental Pathological Findings following Adjusting Enoxaparin Dosage in Thrombophilic Women: Secondary Analysis of a Randomized Controlled Trial.
Topics: Adolescent; Adult; Anticoagulants; Data Interpretation, Statistical; Drug Administration Schedule; E | 2019 |
Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Aspirin; Birth Weight; Embryo Implantation; Enoxaparin; Female; Fibrinoly | 2014 |
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Clinical Protocols; Drug Administration Sched | 2015 |
Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Drug Therapy, Combination; Enoxaparin; Fe | 2015 |
Adjusting enoxaparin dosage according to anti-FXa levels and pregnancy outcome in thrombophilic women. A randomised controlled trial.
Topics: Adult; Anticoagulants; Birth Weight; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Infant, Newbo | 2016 |
The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Middle A | 2018 |
Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.
Topics: Adult; Anticoagulants; DNA; Embryo Implantation; Embryo Transfer; Enoxaparin; Factor V; Female; Fert | 2008 |
Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Dose-Response Relationship, Drug; Drug Administratio | 2010 |
Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women.
Topics: Adult; Alkaline Phosphatase; Anticoagulants; Bone and Bones; Enoxaparin; Female; Gestational Age; Hu | 2011 |
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Biomarkers; Chronic Disease; Doubl | 2011 |
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Drug Therapy, Combination; Earl | 2011 |
Outcome of pregnancies in women with thrombophilic disorders.
Topics: Abortion, Habitual; Adult; Anticoagulants; Enoxaparin; Female; Fetal Death; Humans; Live Birth; Preg | 2010 |
Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia.
Topics: Abortion, Habitual; Adult; Birth Rate; Enoxaparin; Family Health; Female; Fibrinolytic Agents; Human | 2003 |
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Topics: Aspirin; Birth Weight; Enoxaparin; Female; Fetal Death; Folic Acid; Heparin, Low-Molecular-Weight; H | 2004 |
Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Blood Coagulation Disorders; Case-Control Studies; | 2004 |
Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.
Topics: Abortion, Habitual; Dose-Response Relationship, Drug; Drug Hypersensitivity; Enoxaparin; Female; Hem | 2005 |
Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
Topics: Abortion, Habitual; Adult; Anticoagulants; Enoxaparin; Female; Fibrin Fibrinogen Degradation Product | 2005 |
Hypofibrinolysis, thrombophilia, osteonecrosis.
Topics: Adult; Analysis of Variance; Blood Coagulation Disorders; Child; Drug Administration Schedule; Enoxa | 2001 |
Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia.
Topics: Adolescent; Anticoagulants; Antineoplastic Agents; Asparaginase; Blood Coagulation Factors; Child; C | 2001 |
Low molecular weight heparin prevents activation of coagulation in a hypobaric environment.
Topics: Adult; Air Pressure; Aircraft; Anticoagulants; Antithrombin III; Blood Coagulation; Enoxaparin; Hepa | 2001 |
Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Cesarean Section; Dalteparin; Enoxaparin; Facto | 2001 |
Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.
Topics: Adult; Colitis, Ulcerative; Double-Blind Method; Female; Hemostasis; Heparin, Low-Molecular-Weight; | 2007 |
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.
Topics: Adult; Dalteparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Pregnancy; Pregnancy Complicatio | 2014 |
Use of heparin in women with early and late miscarriages with and without thrombophilia.
Topics: Abortion, Habitual; Adult; Age Factors; Aspirin; Biomarkers; Case-Control Studies; Dalteparin; Drug | 2009 |
Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Anti | 2002 |
Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
Topics: Administration, Oral; Aged; Atrial Fibrillation; Biomarkers; Blood Coagulation Factors; Dalteparin; | 2003 |
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Coagulation Factors; Dalteparin; Female; | 2003 |
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anticoagulants; Dalteparin; Death, Sudden; Double-Bli | 2004 |
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anticoagulants; Dalteparin; Death, Sudden; Double-Bli | 2004 |
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anticoagulants; Dalteparin; Death, Sudden; Double-Bli | 2004 |
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anticoagulants; Dalteparin; Death, Sudden; Double-Bli | 2004 |
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Topics: Adult; Anticoagulants; Antithrombin III; Biomarkers; Blood Coagulation; Dalteparin; Female; Heparin, | 2007 |
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial.
Topics: Adult; Anticoagulants; Bone Density; Bone Diseases, Metabolic; Dalteparin; Female; Humans; Middle Ag | 2007 |
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
Topics: Adult; Anticoagulants; Dalteparin; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 2007 |
The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
Topics: Adult; Anticoagulants; Case-Control Studies; Dalteparin; Factor V; Female; Hemostasis; Hemostatics; | 2001 |
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthropl | 2002 |
Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Huma | 2007 |
87 other studies available for dalteparin and Thrombophilia
| Article | Year |
|---|---|
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
Topics: Anticoagulants; Cerebral Infarction; Clopidogrel; Computed Tomography Angiography; Coronavirus Infec | 2020 |
Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis.
Topics: Adult; Anticoagulants; Case-Control Studies; Factor Xa Inhibitors; Female; Heparin, Low-Molecular-We | 2017 |
[Pulmonary embolism in a girl with nephrotic syndrome and factor V Leiden - case report].
Topics: Adolescent; Anticoagulants; Antithrombin III; Factor V; Female; Humans; Mycophenolic Acid; Nadropari | 2018 |
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
Topics: Analysis of Variance; Animals; Antithrombins; Atrial Fibrillation; Cell Proliferation; Dabigatran; F | 2017 |
[Successful pregnancy outcome in the woman with thrombophilia and multiple miscarriages].
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Cesarean Section; Factor V; Female; Heterozygote | 2003 |
Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.
Topics: Administration, Oral; Animals; Anticoagulants; Arginine; Blood Coagulation Tests; Disease Models, An | 2005 |
[Thrombophilia, anticoagulant therapy and pregnancy].
Topics: Adult; Anticoagulants; Female; Heparin, Low-Molecular-Weight; Humans; Maternal Mortality; Nadroparin | 1998 |
[Fraxiparin in the treatment of thrombophilia in angiopathy].
Topics: Adult; Anticoagulants; Female; Humans; Male; Middle Aged; Nadroparin; Peripheral Vascular Diseases; | 2001 |
[Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease].
Topics: Aged; Aged, 80 and over; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Female; | 2020 |
Multifactorial Painful Leg Ulcers Due to Hyperhomocysteinemia, Plasminogen Activator Inhibitor-1 4G/5G Heterozygote Gene Mutation, and Beta Thalassemia Minor: A Case Report.
Topics: Bandages; beta-Thalassemia; Biopsy; Diagnosis, Differential; Enoxaparin; Fibrinolytic Agents; Humans | 2019 |
Long-term Anticoagulation Prevents Progression of Stages I and II Primary Osteonecrosis of the Hip in Patients With Familial Thrombophilia.
Topics: Adult; Anticoagulants; Disease Progression; Enoxaparin; Female; Femur Head Necrosis; Fibrinolysis; F | 2020 |
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.
Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Azithromycin; Combined Moda | 2020 |
Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).
Topics: Aged; Aged, 80 and over; Anticoagulants; Body Weight; C-Reactive Protein; COVID-19; Dose-Response Re | 2021 |
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anticoagulants; Blood Coagulation Tests; Blood Proteins; | 2021 |
Cerebral Venous Thrombosis and Hypercoagulability Associated With In Vitro Fertilization.
Topics: Adult; Anticoagulants; Enoxaparin; Female; Fertilization in Vitro; Humans; Intracranial Thrombosis; | 2021 |
Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
Topics: Abortion, Habitual; Abortion, Threatened; Adult; Anticoagulants; Enoxaparin; Female; Humans; Live Bi | 2017 |
Synchronous Cardiopulmonary Consequences of the Hypercoagulable State Associated With Cancer.
Topics: Adenocarcinoma; Anticoagulants; Brain Ischemia; Computed Tomography Angiography; Endocarditis, Non-I | 2019 |
[Parkes-Weber syndrome and pregnancy: anaesthetic implications].
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anticoagulants; Arteriovenous Malformations; Emb | 2013 |
Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Anticoagulants; Blood Coagulation; Blood Coagulation T | 2013 |
Medical treatment of osteonecrosis of the knee associated with thrombophilia-hypofibrinolysis.
Topics: Adult; Aged; Blood Coagulation Disorders; Disease Progression; Enoxaparin; Female; Fibrinolysis; Fib | 2014 |
Activated clotting time monitoring during osteocutaneous free fibula flap surgery.
Topics: Aged; Anticoagulants; Blood Coagulation; Carcinoma, Squamous Cell; Enoxaparin; Facial Neoplasms; Fem | 2015 |
Upper-extremity deep venous thrombosis after whole blood donation: report of three cases from a single blood center.
Topics: Adolescent; Adult; Androstenes; Blood Donors; Contraceptives, Oral, Hormonal; Drug Substitution; Eme | 2015 |
Venous Thromboembolism after Allogeneic Pediatric Hematopoietic Stem Cell Transplantation: A Single-Center Study.
Topics: Activated Protein C Resistance; Adolescent; Allografts; Catheterization, Central Venous; Child; Chil | 2015 |
Inherited antithrombin deficiency and anabolic steroids: a risky combination.
Topics: Antithrombins; Chest Pain; Dyspnea; Enoxaparin; Fibrinolytic Agents; Hemoptysis; Humans; Injections, | 2016 |
Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Topics: Adult; Anticoagulants; Dose-Response Relationship, Drug; Enoxaparin; Female; Humans; Injections, Sub | 2008 |
Pulmonary embolism associated with protein C deficiency and abuse of anabolic-androgen steroids.
Topics: Anticoagulants; Blood Coagulation Factors; Dalteparin; Doping in Sports; Enoxaparin; Hematoma, Subdu | 2010 |
[Summary and perspectives. Rivaroxaban].
Topics: Administration, Oral; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Comorbidity; Enoxap | 2008 |
Paget-Schroetter syndrome forerunning the diagnoses of thoracic outlet syndrome and thrombophilia.
Topics: Activated Protein C Resistance; Anticoagulants; Aspirin; Enoxaparin; Factor V; Heterozygote; Humans; | 2010 |
Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective.
Topics: Adolescent; Anticoagulants; Child; Child, Preschool; Cost-Benefit Analysis; Decision Support Techniq | 2009 |
[Anesthesia in a patient with homocystinuria and severe pulmonary embolism].
Topics: Acenocoumarol; Aggression; Anesthesia, General; Anesthetics; Anticoagulants; Contraindications; Enox | 2009 |
Stability of plasma anti-Xa activity in low-molecular-weight heparin monitoring.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Preservation; Child; | 2010 |
New observations in postpartum ovarian vein thrombosis: experience of single center.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Early Diagnosis; Enoxaparin; Female; Humans; Incid | 2010 |
Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy.
Topics: Adult; Cross-Sectional Studies; Drug Administration Schedule; Drug Monitoring; Enoxaparin; Factor Xa | 2010 |
Living donor liver transplantation: usefulness of hemostatic and prothrombotic screening in potential donors.
Topics: Adult; Anticoagulants; Child, Preschool; Enoxaparin; Female; Fibrinogen; Hemostatics; Humans; Infant | 2009 |
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery.
Topics: Adenocarcinoma; Adult; Aged; Anticoagulants; Biomarkers; Carcinoma, Squamous Cell; Combined Modality | 2010 |
Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.
Topics: Adolescent; Anticoagulants; Asparaginase; Child; Child, Preschool; Enoxaparin; Female; Genetic Predi | 2010 |
Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Electrolysis; Endothelial Cells; Enoxaparin; Fib | 2010 |
Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications.
Topics: Adult; Anticoagulants; Enoxaparin; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Com | 2011 |
Saddle pulmonary thromboembolism with zero Wells' score.
Topics: Anticoagulants; Blood Coagulation; Clinical Competence; Critical Pathways; Diagnosis, Differential; | 2011 |
[Gastrointestinal stromal tumor in pregnancy and control. Case report].
Topics: Adult; Anticoagulants; Cesarean Section; Embolism, Amniotic Fluid; Emergencies; Enoxaparin; Female; | 2010 |
Cerebral venous sinus thrombosis at high altitude.
Topics: Altitude; Anticoagulants; Enoxaparin; Factor V; Female; Humans; Middle Aged; Phenprocoumon; Radiogra | 2012 |
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Topics: Adult; Aged; Anticoagulants; Canada; Catheterization; Coumarins; Disease Management; Drug Utilizatio | 2012 |
[Usefulness of a scoring system on perinatal outcomes in pregnant women with thrombophilia in the effectiveness of an enoxaparin-based intervention].
Topics: Adult; Anticoagulants; Enoxaparin; Female; Humans; Pregnancy; Pregnancy Complications, Hematologic; | 2012 |
Preventing adverse obstetric outcomes in women with genetic thrombophilia.
Topics: Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Pregnancy; Pregnancy Complication | 2002 |
Upper-extremity deep venous thrombosis complicating whole-blood donation.
Topics: Adult; Blood Donors; Contraceptives, Oral, Sequential; Enoxaparin; Female; Humans; Risk Factors; Thr | 2004 |
The long and winding road ... towards LMWH for pregnancy loss.
Topics: Abortion, Habitual; Clinical Protocols; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Humans; P | 2005 |
Enoxaparin prevents progression of stages I and II osteonecrosis of the hip.
Topics: Arthroplasty, Replacement, Hip; Blood Coagulation Disorders; Disease Progression; Enoxaparin; Female | 2005 |
The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibito
Topics: Anticoagulants; Coronary Disease; Drug Interactions; Endothelium, Vascular; Enoxaparin; Fibrinolytic | 2005 |
Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study.
Topics: Abortion, Habitual; Enoxaparin; Female; Humans; Infant, Newborn; Live Birth; Pregnancy; Pregnancy Co | 2005 |
Thrombophilia and pregnancy loss in first intended pregnancy.
Topics: Abortion, Habitual; Abortion, Spontaneous; Enoxaparin; Female; Gravidity; Humans; Pregnancy; Pregnan | 2005 |
Inherited thrombophilia: treatment during pregnancy.
Topics: Adult; Anticoagulants; Birth Weight; Cesarean Section; Delivery, Obstetric; Enoxaparin; Female; Feta | 2006 |
The natural course of women with recurrent fetal loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enoxaparin; Female; Fibrinolyt | 2006 |
The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibito
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Drug Administration Schedule; Drug Therapy, Combinat | 2006 |
A fatal case of enoxaparin induced skin necrosis and thrombophilia.
Topics: Aged; Anticoagulants; Diagnosis, Differential; Drug Eruptions; Enoxaparin; Factor V; Factor VIII; Fa | 2006 |
[Analgesia for childbirth in a patient with factor V Leiden mutation].
Topics: Activated Protein C Resistance; Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anticoagulants; | 2007 |
Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Topics: Adult; Anticoagulants; Diagnosis, Differential; Enoxaparin; Female; Humans; Injections, Subcutaneous | 2007 |
[Hereditary thrombophilia and systemic sclerosis. An unusual case report].
Topics: Adult; Anticoagulants; Blood Coagulation Disorders, Inherited; Drug Therapy, Combination; Enoxaparin | 2007 |
Lung transplantation in a patient with a thrombophilic disorder.
Topics: Adult; Cystic Fibrosis; Enoxaparin; Fatal Outcome; Female; Heparin; Heterozygote; Humans; Hypertensi | 2008 |
Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
Topics: Abortion, Habitual; Adult; Anticoagulants; Cohort Studies; Enoxaparin; Female; Humans; Live Birth; P | 2008 |
[Stents, antiplatelet therapy, and surgery].
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cesarean Section; Enoxaparin; Female | 2008 |
The role of heparin in alleviating complement-mediated acute intravascular haemolysis.
Topics: 3' Untranslated Regions; Acute Disease; Adult; Anemia, Hemolytic, Autoimmune; Azathioprine; Combined | 2008 |
Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin.
Topics: Adult; Anticoagulants; Biomarkers; Bone Density; Child; Drug Eruptions; Enoxaparin; Female; Heparin; | 1998 |
Deep venous thrombosis in a preterm newborn of a mother with activated protein C resistance.
Topics: Adult; Blood Coagulation Disorders; Enoxaparin; Female; Humans; Infant, Newborn; Infant, Premature, | 1998 |
Risk factors and management of patients with upper limb deep vein thrombosis.
Topics: Activated Protein C Resistance; Adult; Aged; Antithrombin III Deficiency; Drug Therapy, Combination; | 2000 |
Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Topics: 3' Untranslated Regions; Abortion, Habitual; Activated Protein C Resistance; Adult; Anticoagulants; | 2000 |
Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy.
Topics: Anemia; Anticoagulants; Dalteparin; Delivery, Obstetric; Dextrans; Enoxaparin; Female; Hemorrhage; H | 2000 |
[Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia].
Topics: Abortion, Habitual; Adult; Biomarkers; Embryo Loss; Enoxaparin; Female; Fibrinolytic Agents; Heparin | 2001 |
Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin.
Topics: Animals; Anticholesteremic Agents; Anticoagulants; Aorta; cdc42 GTP-Binding Protein; Cells, Cultured | 2002 |
Prophylactic Dose of Dalteparin in Pregnant Women With History of Venous Thromboembolisms and/or Thrombophilia: Real-World Data.
Topics: Anticoagulants; Dalteparin; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pr | 2023 |
Recurrent cerebral ischaemia in a pregnant woman with patent foramen ovale II° and thrombophilia.
Topics: Adult; Anticoagulants; Brain Ischemia; Dalteparin; Female; Foramen Ovale, Patent; Humans; Injections | 2014 |
TIPPing practice away from anticoagulation in pregnancy.
Topics: Dalteparin; Female; Fibrinolytic Agents; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; | 2014 |
Heartache and bellyache: limited English proficiency perpetuating recurrent thromboembolic events.
Topics: Anticoagulants; Communication Barriers; Dalteparin; Female; Humans; Language; Medication Adherence; | 2015 |
Dalteparin for pregnant women with thrombophilia.
Topics: Dalteparin; Female; Fibrinolytic Agents; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; | 2015 |
Dalteparin for pregnant women with thrombophilia.
Topics: Dalteparin; Female; Fibrinolytic Agents; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; | 2015 |
Dalteparin for pregnant women with thrombophilia.
Topics: Dalteparin; Female; Fibrinolytic Agents; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; | 2015 |
Dalteparin for pregnant women with thrombophilia - authors' reply.
Topics: Dalteparin; Female; Fibrinolytic Agents; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; | 2015 |
A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin.
Topics: Adult; Antibody Specificity; Antigens, Human Platelet; Autoantibodies; Autoantigens; Dalteparin; Dos | 2008 |
Kinetics of D-dimer after general surgery.
Topics: Abdomen; Abdominal Neoplasms; Adult; Aged; Anticoagulants; Cohort Studies; Dalteparin; Female; Fibri | 2009 |
Should low molecular weight heparin dosing be based on anti-Xa assays in antiphospholipid syndrome?
Topics: Adult; Anti-Bacterial Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome | 2013 |
Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clinical Laboratory Techniques; Clopidogrel; Da | 2002 |
Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Female; F | 2007 |
The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy.
Topics: Anticoagulants; Dalteparin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; | 2007 |
Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Clopidogrel; Dalteparin; | 2001 |
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubic | 2001 |
The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.
Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Dalteparin; Factor Xa Inhibitors; Female | 2002 |
Nail discoloration due to tinzaparin sodium.
Topics: Adult; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Nail Diseases; Pigmentati | 2012 |
The association between race and venous thromboembolism risk after initiation of chemotherapy: An analysis of the SAVE-ONCO trial control arm.
Topics: Adult; Aged; Anticoagulants; Antineoplastic Agents; Control Groups; Controlled Clinical Trials as To | 2017 |